Article
Investigating the role of genomic drivers of MET pathway dysregulation in the heterogeneity of pleomorphic lung carcinoma
2019-01-01
Abstract excerpt
Background: Pleomorphic Lung Carcinoma (PC) is a rare lung cancer that is aggressive and poorly responsive to treatments. It is a highly heterogenous tumour and unique as it has at least 10% dedifferentiated sarcomatoid component alongside its epithelial components. Recent data have demonstrated a high frequency of mutations in the MET receptor that may support epithelial to mesenchymal transition (EMT) as an impo...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 0544b887-43cf-5a58-a94d-1c05dbef89c7
- DOI
- 10.25560/78719
